tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Health In Tech Reports 90% Revenue Increase in Q3 2025

Story Highlights
Health In Tech Reports 90% Revenue Increase in Q3 2025

TipRanks Cyber Monday Sale

An announcement from Health In Tech, Inc. Class A ( (HIT) ) is now available.

On November 10, 2025, Health In Tech, Inc. held a conference call to discuss its Q3 2025 financial results, reporting a 90% year-over-year revenue increase to $8.5 million, driven by an expanded distribution network. The company launched a large-employer underwriting capability and announced a blockchain-enabled platform, HITChain, in collaboration with AlphaTON Capital Corp., aiming to improve claims processing efficiency. Health In Tech will host the InsurTech Summit in Davos during the World Economic Forum week in January 2026, highlighting its role in the global innovation stage.

The most recent analyst rating on (HIT) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Health In Tech, Inc. Class A stock, see the HIT Stock Forecast page.

Spark’s Take on HIT Stock

According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.

Health In Tech, Inc. demonstrates strong financial performance with robust revenue growth and a solid balance sheet. The positive sentiment from the earnings call further supports the company’s growth prospects. However, technical indicators suggest a bearish trend, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.

To see Spark’s full report on HIT stock, click here.

More about Health In Tech, Inc. Class A

Health In Tech, Inc. operates in the healthcare insurance technology industry, offering a platform that facilitates insurance brokerage and underwriting services. The company focuses on expanding its distribution network and enhancing its platform capabilities to serve both small and large employers.

Average Trading Volume: 471,653

Technical Sentiment Signal: Strong Buy

Current Market Cap: $164.7M

Find detailed analytics on HIT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1